Literature DB >> 19077104

Expression of Foxp3+CD4+CD25+ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum.

Y Xu1, K-J Zhu, N Zhu, D-H Jiang, X-Z Chen, H Cheng.   

Abstract

BACKGROUND: Condyloma acuminatum (CA) is a disease that appears as proliferative lesions of the genital epithelium caused by human papillomavirus (HPV) infection. The balance between type 1 and type 2 T-cell subsets in patients with CA is thought to modulate antiviral immunity. CD4+CD25+ regulatory T cells (Tregs) inhibit proliferation and cytokine production by both T-helper (Th)1 and Th2 cells and reversibly suppress CTL-mediated immunity. A better understanding of the mechanisms of T-cell regulation in CA might help in developing more effective therapeutic strategies. Objective. To evaluate the balance of Th1/Th2 and Tc1/Tc2 and to assess their correlation with changes in number of Tregs in CA.
METHODS: The percentage of Th1, Th2, Tc1, Tc2 and Tregs were detected by flow cytometry after intracellular staining for cytokines (interferon-gamma and interleukin-4) and Foxp3 of T lymphocytes in the peripheral blood of 30 patients and 20 healthy volunteers.
RESULTS: Patients with CA showed a decreased proportion of Th1 and Tc1 cells and a decreased ratio of Th1/Th2 and Tc1/Tc2. In particular, strikingly decreased ratios of Th1/Th2 were found in 15 patients with relapsed CA (P < 0.01). The mean +/- SD number of Foxp3+CD4+CD25+ Tregs increased significantly in patients with CA (3.37 +/- 1.03%) and patients with relapsed CA (4.68 +/- 1.17%) compared with healthy controls (1.18 +/- 0.53%) (P < 0.001).
CONCLUSION: Tregs appear to downregulate cytokine expression in both Tc1 and Th1 subsets of effector T cells, which may be responsible for antivirus responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077104     DOI: 10.1111/j.1365-2230.2008.03001.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

1.  Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts.

Authors:  Manjula Singh; Deepshi Thakral; Narayan Rishi; Hemanta Kumar Kar; Dipendra Kumar Mitra
Journal:  Virusdisease       Date:  2017-06-13

Review 2.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer.

Authors:  Jasenka Wagner; Sanela Štibi; Nikica Selak; Ilija Alvir; Ivica Mamić; Luka Marcelić; Lucija Šušnjar; Mario Puljiz; Marija Heffer; Damir Danolić
Journal:  Wien Med Wochenschr       Date:  2022-01-18

4.  Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.

Authors:  Alexandra V Lucs; James A DeVoti; Lynda Hatam; Ali Afzal; Allan L Abramson; Bettie M Steinberg; Vincent R Bonagura
Journal:  J Clin Med       Date:  2015-03       Impact factor: 4.241

5.  Normalization of regulatory T cells, serum TGF-β1, and LTN after 5-aminolevulinic acid-photodynamic therapy in patients with condyloma acuminate.

Authors:  Zhang-Yu Bu; Xiao-Hong Yu; Li-Min Wu; Jian-Bo Zhong; Ping Yang; Jian Chen
Journal:  Exp Ther Med       Date:  2017-05-03       Impact factor: 2.447

6.  The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix.

Authors:  Bohan Li; Ling Zhang; Jianguo Zhao; Guichun Tan; Wenwen Zhang; Na Zhang; Jing Tian; Pengpeng Qu
Journal:  Infect Agent Cancer       Date:  2019-06-28       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.